Seach Medical Group Ltd (TLV: SEMG)
Israel
· Delayed Price · Currency is ILS · Price in ILA
279.10
+3.20 (1.16%)
Nov 19, 2024, 5:24 PM IDT
Seach Medical Group Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Revenue | 162.4 | 150.32 | 134.21 | 67.34 | 36.8 | 28.83 | Upgrade
|
Revenue Growth (YoY) | 14.23% | 12.01% | 99.30% | 82.98% | 27.63% | 55.45% | Upgrade
|
Cost of Revenue | 117.39 | 112.93 | 95.91 | 44.34 | 19.86 | 15.09 | Upgrade
|
Gross Profit | 45.02 | 37.4 | 38.3 | 23 | 16.94 | 13.74 | Upgrade
|
Selling, General & Admin | 36.75 | 38.23 | 32.74 | 16.16 | 10.57 | 7.32 | Upgrade
|
Research & Development | 1.67 | 1.76 | 1.45 | 2.31 | 1.93 | 1.81 | Upgrade
|
Other Operating Expenses | 0.83 | -0.23 | 0.08 | 0.12 | -0.24 | -0.05 | Upgrade
|
Operating Expenses | 39.26 | 39.76 | 34.27 | 18.59 | 12.25 | 9.07 | Upgrade
|
Operating Income | 5.76 | -2.37 | 4.03 | 4.41 | 4.69 | 4.67 | Upgrade
|
Interest Expense | -1.55 | -1.81 | -0.94 | -0.17 | -0.09 | -0.32 | Upgrade
|
Interest & Investment Income | 0.32 | 0.25 | 0.01 | 0.25 | 0.41 | 0.01 | Upgrade
|
Earnings From Equity Investments | -0.19 | 0.19 | -1.24 | -1 | -1.55 | -0.78 | Upgrade
|
Other Non Operating Income (Expenses) | -0.88 | -0.88 | -0.73 | -0.25 | -0.61 | -0.15 | Upgrade
|
EBT Excluding Unusual Items | 3.45 | -4.61 | 1.14 | 3.24 | 2.83 | 3.43 | Upgrade
|
Impairment of Goodwill | -8.03 | -5.76 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | -1.57 | -2.03 | -5.04 | 0.49 | 6.12 | 3.96 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.32 | -0.32 | -0.17 | 0.01 | - | -0.02 | Upgrade
|
Other Unusual Items | 2.44 | 2.44 | 0 | 2.49 | 4.35 | -28.36 | Upgrade
|
Pretax Income | -4.04 | -10.28 | -4.07 | 6.23 | 13.3 | -20.99 | Upgrade
|
Income Tax Expense | 3.09 | 1.59 | 1.2 | 1.01 | 1.33 | 1.57 | Upgrade
|
Earnings From Continuing Operations | -7.13 | -11.87 | -5.27 | 5.23 | 11.97 | -22.55 | Upgrade
|
Minority Interest in Earnings | -0.09 | 1.36 | 1.86 | 0.12 | - | - | Upgrade
|
Net Income | -7.22 | -10.51 | -3.41 | 5.35 | 11.97 | -22.55 | Upgrade
|
Net Income to Common | -7.22 | -10.51 | -3.41 | 5.35 | 11.97 | -22.55 | Upgrade
|
Net Income Growth | - | - | - | -55.30% | - | - | Upgrade
|
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 33 | 26 | Upgrade
|
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 33 | 26 | Upgrade
|
Shares Change (YoY) | 3.54% | - | 0.79% | 3.61% | 23.40% | 15.00% | Upgrade
|
EPS (Basic) | -0.21 | -0.31 | -0.10 | 0.16 | 0.37 | -0.85 | Upgrade
|
EPS (Diluted) | -0.21 | -0.31 | -0.10 | 0.16 | 0.37 | -0.85 | Upgrade
|
EPS Growth | - | - | - | -56.86% | - | - | Upgrade
|
Free Cash Flow | -4.28 | -0.67 | 16.16 | -10.02 | -10.23 | -2.44 | Upgrade
|
Free Cash Flow Per Share | -0.13 | -0.02 | 0.47 | -0.30 | -0.31 | -0.09 | Upgrade
|
Gross Margin | 27.72% | 24.88% | 28.54% | 34.16% | 46.04% | 47.67% | Upgrade
|
Operating Margin | 3.54% | -1.57% | 3.00% | 6.55% | 12.74% | 16.20% | Upgrade
|
Profit Margin | -4.45% | -6.99% | -2.54% | 7.94% | 32.52% | -78.22% | Upgrade
|
Free Cash Flow Margin | -2.63% | -0.44% | 12.04% | -14.88% | -27.80% | -8.46% | Upgrade
|
EBITDA | 8.54 | 1.29 | 9.28 | 7.39 | 6.16 | 5.41 | Upgrade
|
EBITDA Margin | 5.26% | 0.86% | 6.92% | 10.97% | 16.74% | 18.78% | Upgrade
|
D&A For EBITDA | 2.78 | 3.66 | 5.25 | 2.98 | 1.47 | 0.74 | Upgrade
|
EBIT | 5.76 | -2.37 | 4.03 | 4.41 | 4.69 | 4.67 | Upgrade
|
EBIT Margin | 3.54% | -1.57% | 3.00% | 6.55% | 12.74% | 16.20% | Upgrade
|
Effective Tax Rate | - | - | - | 16.14% | 10.02% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.